A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinidine barbiturate
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Ceritinib.
Quinidine barbiturate
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ceritinib.
Quinidine barbiturate
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Ceritinib.
Quinidine barbiturate
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ceritinib.
Quinidine barbiturate
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Ceritinib.
Quinidine barbiturate
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ceritinib.
Quinidine barbiturate
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ceritinib.
Quinidine barbiturate
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Ceritinib.
Quinidine barbiturate
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Ceritinib.
Quinidine barbiturate
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ceritinib.
Quinidine barbiturate
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ceritinib.
Quinidine barbiturate
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ceritinib.
Quinidine barbiturate
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ceritinib.
Quinidine barbiturate
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Ceritinib.
Quinidine barbiturate
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Ceritinib.
Quinidine barbiturate
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ceritinib.
Quinidine barbiturate
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Ceritinib.
Quinidine barbiturate
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Ceritinib.
Quinidine barbiturate
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Ceritinib.
Quinidine barbiturate
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ceritinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3